By Viviane Trojan
2 de July de 2024
Life Sciences’ Brazil Global Guide 2024 is now available
We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2024 Global Practice Guide!
Our partners Priscila Kashiwabara and Viviane Trojan, along with attorneys at law Gustavo Vicenti and Giovanna Verginelli Mezher, authored the Life Sciences 2024 guide for Brazil, that outlines the regulatory framework for pharmaceuticals and medical devices, detailing the legislation, regulatory bodies and procedures for securing approvals and handling appeals. It covers categorisation, clinical trials, marketing authorizations and ongoing obligations.
The guide also emphasizes ANVISA’s role in regulation, the stringent requirements for biologics and the procedures for compassionate use and post-marketing surveillance. Additionally, it addresses manufacturing authorizations, distribution regulations and measures against counterfeit products.
For more details, click here.
Share:
Last by Viviane Trojan
30 de July de 2025
Weekly Update for Intellectual Property in Health
On July 28th, 2025, the Official Gazette of the Union (DOU) published Ministerial Ordinance GM/MS No. 7,687, dated July 24, 2025, issued … Weekly Update for Intellectual Property in Health
16 de April de 2025
Medicinal Cannabis Review: Public Consultation 1.316/2025 open
The Public Consultation (CP) No. 1.316/2025, which aims to initiate the review process of Collegiate Board Resolution (RDC) No. 327/2019 from the … Medicinal Cannabis Review: Public Consultation 1.316/2025 open
15 de April de 2025
Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required
The Federal Senate has approved a bill (PLS nº 404/2018) that extends the protection period for new plant varieties (cultivars). According to … Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required